{"id":"https://openalex.org/W3017157828","doi":"https://doi.org/10.1002/cpt.1853","title":"Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value","display_name":"Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value","publication_year":2020,"publication_date":"2020-04-16","ids":{"openalex":"https://openalex.org/W3017157828","doi":"https://doi.org/10.1002/cpt.1853","mag":"3017157828","pmid":"https://pubmed.ncbi.nlm.nih.gov/32298471"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.1853","doi":"https://doi.org/10.1002/cpt.1853","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt.1853","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078448821","display_name":"Anthony V. Serritella","orcid":"https://orcid.org/0009-0006-9887-3054","observed_orcids":["https://orcid.org/0009-0006-9887-3054"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony V. Serritella","raw_affiliation_strings":["Department of Medicine The University of Chicago Chicago Illinois USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine The University of Chicago Chicago Illinois USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049706073","display_name":"Garth William Strohbehn","orcid":"https://orcid.org/0000-0003-2973-3040","observed_orcids":["https://orcid.org/0000-0003-2973-3040"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garth W. Strohbehn","raw_affiliation_strings":["Department of Medicine The University of Chicago Chicago Illinois USA","Value in Cancer Care Consortium Ann Arbor Michigan USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine The University of Chicago Chicago Illinois USA","institution_ids":["https://openalex.org/I40347166"]},{"raw_affiliation_string":"Value in Cancer Care Consortium Ann Arbor Michigan USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020242154","display_name":"Daniel A. Goldstein","orcid":"https://orcid.org/0000-0002-8082-9622","observed_orcids":["https://orcid.org/0000-0002-8082-9622"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL","US"],"is_corresponding":false,"raw_author_name":"Daniel A. Goldstein","raw_affiliation_strings":["Davidoff Cancer Center Rabin Medical Center Petah Tikva Israel","Department of Health Policy and Management Gillings School of Public Health University of North Carolina Chapel Hill North Carolina USA","Tel Aviv University Tel Aviv Israel","Value in Cancer Care Consortium Ann Arbor Michigan USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Davidoff Cancer Center Rabin Medical Center Petah Tikva Israel","institution_ids":["https://openalex.org/I2800389475"]},{"raw_affiliation_string":"Department of Health Policy and Management Gillings School of Public Health University of North Carolina Chapel Hill North Carolina USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Tel Aviv University Tel Aviv Israel","institution_ids":["https://openalex.org/I16391192"]},{"raw_affiliation_string":"Value in Cancer Care Consortium Ann Arbor Michigan USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034493174","display_name":"Allen S. Lichter","orcid":"https://orcid.org/0000-0002-0378-1258","observed_orcids":["https://orcid.org/0000-0002-0378-1258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allen S. Lichter","raw_affiliation_strings":["Value in Cancer Care Consortium Ann Arbor Michigan USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value in Cancer Care Consortium Ann Arbor Michigan USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068268371","display_name":"Mark J. Ratain","orcid":"https://orcid.org/0000-0002-0938-4392","observed_orcids":["https://orcid.org/0000-0002-0938-4392"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark J. Ratain","raw_affiliation_strings":["Department of Medicine The University of Chicago Chicago Illinois USA","Value in Cancer Care Consortium Ann Arbor Michigan USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine The University of Chicago Chicago Illinois USA","institution_ids":["https://openalex.org/I40347166"]},{"raw_affiliation_string":"Value in Cancer Care Consortium Ann Arbor Michigan USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5068268371"],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":1.1887,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.85375494,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"108","issue":"3","first_page":"487","last_page":"493"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.8291000127792358,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.8291000127792358,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.09220000356435776,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.05649999901652336,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-drug-costs","display_name":"cancer drug costs","score":0.6899999976158142},{"id":"https://openalex.org/keywords/cost-containment","display_name":"cost containment","score":0.5870000123977661},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5320000052452087},{"id":"https://openalex.org/keywords/administration-frequency","display_name":"administration frequency","score":0.8569999933242798},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.7889999747276306},{"id":"https://openalex.org/keywords/value-based-health-care","display_name":"value-based care","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.9712616205215454},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7484758496284485},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6500555872917175},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5899927616119385},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4460848867893219},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3143768906593323}],"mesh":[{"descriptor_ui":"D000070376","descriptor_name":"Value-Based Health Insurance","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017850","descriptor_name":"Economics, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019984","descriptor_name":"Quality Indicators, Health Care","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt.1853","doi":"https://doi.org/10.1002/cpt.1853","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt.1853","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:32298471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32298471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1571401550","https://openalex.org/W1636203444","https://openalex.org/W1825036120","https://openalex.org/W1977551011","https://openalex.org/W1999130958","https://openalex.org/W2006972833","https://openalex.org/W2067306752","https://openalex.org/W2091865314","https://openalex.org/W2100373994","https://openalex.org/W2104932289","https://openalex.org/W2107779395","https://openalex.org/W2111127657","https://openalex.org/W2128758225","https://openalex.org/W2157345824","https://openalex.org/W2158269380","https://openalex.org/W2161349247","https://openalex.org/W2169052701","https://openalex.org/W2290111006","https://openalex.org/W2527826246","https://openalex.org/W2527905628","https://openalex.org/W2601651821","https://openalex.org/W2621194109","https://openalex.org/W2664930764","https://openalex.org/W2704285213","https://openalex.org/W2734805455","https://openalex.org/W2772764478","https://openalex.org/W2784507549","https://openalex.org/W2790377120","https://openalex.org/W2793180707","https://openalex.org/W2795001216","https://openalex.org/W2795004907","https://openalex.org/W2795069704","https://openalex.org/W2795164601","https://openalex.org/W2796852226","https://openalex.org/W2888888880","https://openalex.org/W2891743343","https://openalex.org/W2898540195","https://openalex.org/W2902246391","https://openalex.org/W2909586827","https://openalex.org/W2922005522","https://openalex.org/W2946838126","https://openalex.org/W2948726637","https://openalex.org/W2949082582","https://openalex.org/W2957337318","https://openalex.org/W2976280418","https://openalex.org/W2980857918","https://openalex.org/W2980952560","https://openalex.org/W2981939858","https://openalex.org/W3011518560"],"related_works":["https://openalex.org/W4210340546","https://openalex.org/W2949082582","https://openalex.org/W6987933289","https://openalex.org/W2411051473","https://openalex.org/W2126346676","https://openalex.org/W2053225769","https://openalex.org/W2424701229","https://openalex.org/W4253714402","https://openalex.org/W1933028592","https://openalex.org/W2291411466"],"abstract_inverted_index":{"Cancer":[0],"care's":[1],"sustainability":[2],"is":[3,15],"challenged":[4],"by":[5],"drug":[6,19],"expenditures.":[7],"In":[8,56],"the":[9],"absence":[10],"of":[11,44],"systemic":[12],"change,":[13],"innovation":[14],"needed":[16],"to":[17,27,34],"curtail":[18],"costs.":[20],"Interventional":[21],"pharmacoeconomics":[22],"(IVPE)":[23],"utilizes":[24],"clinical":[25],"research":[26],"identify":[28],"safe,":[29],"efficacious,":[30],"cost-conscious":[31],"dosing":[32],"regimens":[33],"extract":[35],"maximum":[36],"value":[37],"from":[38],"expensive":[39],"therapies.":[40],"Strategies":[41],"include":[42],"de-escalation":[43],"dosage,":[45],"treatment":[46],"duration":[47],"and":[48,51,68],"administration":[49],"frequency,":[50],"substitution":[52],"with":[53],"therapeutic":[54],"alternatives.":[55],"this":[57],"review,":[58],"we":[59],"discuss":[60],"how":[61],"IVPE":[62],"strategies":[63],"have":[64],"been":[65],"successfully":[66],"used":[67],"could":[69],"be":[70],"implemented":[71],"going":[72],"forward.":[73]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-04-24T00:00:00"}